99% Savings - Buy Just @1 Rs X
Wergomet 0.125 Mg Tablet is a prescription medicine that is available as a Tablet. It is typically used for the treatment of Post Delivery Bleeding.
The correct dosage of Wergomet 0.125 Mg Tablet depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. For detailed information on this, read through the dosage section.
The most common side effects of Wergomet 0.125 Mg Tablet are Headache, Abdominal Pain, Hypertension. While these are the most often observed Wergomet 0.125 Mg Tablet side effects, there are can be others also. These have been listed below. Such side effects of Wergomet 0.125 Mg Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
It is also important to note that Wergomet 0.125 Mg Tablet has a Unknown effect for pregnant women and Unknown effect on lactating mothers. In addition, Wergomet 0.125 Mg Tablet's effects on the liver, heart and kidney are discussed below in the Wergomet 0.125 Mg Tablet related warnings section.
Individuals suffering from medical conditions like High Blood Pressure must refrain from the use of Wergomet 0.125 Mg Tablet since this can cause severe adverse effects. Some other conditions that can be affected by Wergomet 0.125 Mg Tablet are listed in the contraindications section below.
Besides this, Wergomet 0.125 Mg Tablet may also have severe interaction with some medicines. A complete list of these interactions is given below.
Along with the above-mentioned precautions, remember that taking Wergomet 0.125 Mg Tablet is considered safe while driving, and is addictive.
Wergomet 0.125 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Wergomet 0.125 Mg Tablet safe for pregnant women?
Side effects of Wergomet during pregnancy are not known because scientific research on this topic hasn't been done.
Is the use of Wergomet 0.125 Mg Tablet safe during breastfeeding?
Due to lack of research work on this topic, the side effects of Wergomet for breastfeeding women are not known.
What is the effect of Wergomet 0.125 Mg Tablet on the Kidneys?
Wergomet rarely harms the kidneys.
What is the effect of Wergomet 0.125 Mg Tablet on the Liver?
Wergomet may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Wergomet 0.125 Mg Tablet on the Heart?
Effects of Wergomet on heart can be severe. It is not safe to use without doctor's advice.
If you are suffering from any of the following diseases, you should not take Wergomet 0.125 Mg Tablet unless your doctor advises you to do so -
Is this Wergomet 0.125 Mg Tablet habit forming or addictive?
Wergomet 0.125 Mg Tablet does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
Yes, you can comfortably use machinery or drive after taking Wergomet 0.125 Mg Tablet since it will not make you feel sleepy.
Is it safe?
Yes, but consume Wergomet 0.125 Mg Tablet only on doctor's advice.
Is it able to treat mental disorders?
No, Wergomet 0.125 Mg Tablet cannot treat any kind of mental disorder.
Interaction between Food and Wergomet 0.125 Mg Tablet
Due to the absence of research, it is difficult to say how Wergomet 0.125 Mg Tablet and food will interact.
Interaction between Alcohol and Wergomet 0.125 Mg Tablet
No research has been done on this till date. Therefore, it is not known what the effect of taking Wergomet 0.125 Mg Tablet with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Methergine® (methylergonovine maleate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 331-332
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 837-839